{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:43:35Z","timestamp":1772149415617,"version":"3.50.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"31","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,1]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Immunotactoid glomerulopathy (ITG) is a rare glomerular disease characterized by protein deposition in hollow microtubules on electron microscopy. Patients may present with proteinuria, hematuria, hypertension, and renal insufficiency, and some patients even progress to end-stage renal disease (ESRD). In patients with ESRD, ITG recurs in more than 50% of patients after kidney transplantation; however, there is no clear treatment plan for these patients owing to the limited number of reported cases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>In this study, we report a case of a 58-year-old male who was admitted to our hospital with elevated blood creatinine with proteinuria.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Renal biopsy suggested membranoproliferative glomerulonephritis with findings suggestive of ITG on electron microscopy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>After the first diagnosis of renal insufficiency, the patient was treated with rituximab; however, the patient\u2019s symptoms did not improve, and blood creatinine continued to increase. The patient progressed to ESRD, and 3 years later, kidney transplantation was performed. After surgery, he was regularly treated with tacrolimus, mycophenolate mofetil, and prednisone acetate for antirejection. Five months after surgery, a renal biopsy was performed again due to proteinuria, and the results suggested ITG recurrence. The patient\u2019s blood CD19-positive B-cell count was 0. Therefore, he was not administered rituximab again.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient is now under regular review; his blood creatinine is relatively stable (120\u2013150 mmol\/L), while his 24-hour urine protein quantification is higher than the normal range.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This study expands the number of reported cases of this condition and will be useful to better understand the treatment options for patients with ITG recurrence after kidney transplantation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000043673","type":"journal-article","created":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T23:00:43Z","timestamp":1754089243000},"page":"e43673","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Recurrent immunotactoid glomerulopathy in a kidney transplant recipient: Case report"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4008-1915","authenticated-orcid":false,"given":"Shuxin","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoxuan","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanqian","family":"Cheng","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunbo","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jinyu","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixia","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin Province, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250918","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3109\/01913128009140563","article-title":"The quarterly case: nephrotic syndrome in a middle-aged man.","volume":"1:","author":"Schwartz","year":"1980","journal-title":"Ultrastruct Pathol"},{"key":"R2-20250918","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1046\/j.1523-1755.2003.00853.x","article-title":"Fibrillary and immunotactoid glomerulonephritis: distinct entities with different clinical and pathologic features.","volume":"63","author":"Rosenstock","year":"2003","journal-title":"Kidney Int"},{"key":"R3-20250918","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1093\/ndt\/gfs348","article-title":"Immunotactoid glomerulopathy: clinicopathologic and proteomic study.","volume":"27","author":"Nasr","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"R4-20250918","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.kint.2020.07.037","article-title":"Immunotactoid glomerulopathy is a rare entity with monoclonal and polyclonal variants.","volume":"99","author":"Nasr","year":"2021","journal-title":"Kidney Int"},{"key":"R5-20250918","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.ASN.0000013397.06964.19","article-title":"Immunotactoid glomerulopathy.","volume":"13","author":"Schwartz","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R6-20250918","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/S0140-6736(21)00477-3","article-title":"Immunotactoid glomerulopathy associated with monoclonal gammopathy.","volume":"397","author":"Inotani","year":"2021","journal-title":"Lancet"},{"key":"R7-20250918","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/ndt\/15.6.897","article-title":"Successful treatment of recurrence of immunotactoid glomerulopathy in a kidney allograft recipient.","volume":"15","author":"Carles","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"R8-20250918","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/ki.1987.66","article-title":"Fibrillary glomerulonephritis: an entity with unusual immunofluorescence features.","volume":"31","author":"Alpers","year":"1987","journal-title":"Kidney Int"},{"key":"R9-20250918","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0272-6386(12)70138-5","article-title":"Morphologic and clinical features of fibrillary glomerulonephritis versus immunotactoid glomerulopathy.","volume":"22","author":"Fogo","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"R10-20250918","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1681\/ASN.2017030306","article-title":"DnaJ heat shock protein family B member 9 is a novel biomarker for fibrillary GN.","volume":"29","author":"Dasari","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R11-20250918","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1046\/j.1523-1755.2002.00628.x","article-title":"Fibrillary glomerulonephritis and immunotactoid (microtubular) glomerulopathy are associated with distinct immunologic features.","volume":"62","author":"Bridoux","year":"2002","journal-title":"Kidney Int"},{"key":"R12-20250918","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1182\/blood.V95.11.3467","article-title":"Heavy and light chain primary structures control IgG3 nephritogenicity in an experimental model for cryocrystalglobulinemia.","volume":"95","author":"Rengers","year":"2000","journal-title":"Blood"},{"key":"R13-20250918","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1681\/ASN.2017050566","article-title":"DnaJ Homolog subfamily B member 9 is a putative autoantigen in fibrillary GN.","volume":"29","author":"Andeen","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"R14-20250918","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ekir.2017.07.017","article-title":"DNAJB9 is a specific immunohistochemical marker for fibrillary glomerulonephritis.","volume":"3","author":"Nasr","year":"2018","journal-title":"Kidney Int Rep"},{"key":"R15-20250918","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.kint.2020.06.039","article-title":"Results of a nation-wide cohort study suggest favorable long-term outcomes of clone-targeted chemotherapy in immunotactoid glomerulopathy.","volume":"99","author":"Javaugue","year":"2021","journal-title":"Kidney Int"},{"key":"R16-20250918","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s10157-009-0166-6","article-title":"A case of immunotactoid glomerulopathy exhibiting nephrotic syndrome successfully treated with corticosteroids and antihypertensive therapy.","volume":"13","author":"Kinomura","year":"2009","journal-title":"Clin Exp Nephrol"},{"key":"R17-20250918","doi-asserted-by":"crossref","first-page":"222","DOI":"10.5414\/CN109431","article-title":"Successful treatment with rituximab of immunotactoid glomerulopathy exhibiting nephrotic syndrome.","volume":"90","author":"Karasawa","year":"2018","journal-title":"Clin Nephrol"},{"key":"R18-20250918","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1093\/ndt\/gfz176","article-title":"Proliferative glomerulonephritis with monoclonal immunoglobulin deposits: a nephrologist perspective.","volume":"36","author":"Bridoux","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"R19-20250918","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1093\/ndt\/gfu189","article-title":"Rituximab treatment for fibrillary glomerulonephritis.","volume":"29","author":"Hogan","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"R20-20250918","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1053\/j.akdh.2024.03.003","article-title":"Immunotactoid glomerulopathy.","volume":"31","author":"Abramson","year":"2024","journal-title":"Adv Kidney Dis Health"},{"key":"R21-20250918","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000440815","article-title":"End-stage kidney disease due to fibrillary glomerulonephritis and immunotactoid glomerulopathy \u2013 outcomes in 66 consecutive ANZDATA registry cases.","volume":"42","author":"Mallett","year":"2015","journal-title":"Am J Nephrol"},{"key":"R22-20250918","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9343(90)90104-L","article-title":"Course of renal transplantation in immunotactoid glomerulopathy.","volume":"89","author":"Korbet","year":"1990","journal-title":"Am J Med"},{"key":"R23-20250918","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1016\/j.transproceed.2009.03.100","article-title":"A case of recurrent immunotactoid glomerulopathy in an allograft treated with rituximab.","volume":"41","author":"Sathyan","year":"2009","journal-title":"Transplant Proc"},{"key":"R24-20250918","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0272-6386(12)80167-3","article-title":"De novo immunotactoid glomerulopathy of the renal allograft: possible association with cytomegalovirus infection.","volume":"24","author":"Rao","year":"1994","journal-title":"Am J Kidney Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043673","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T22:01:00Z","timestamp":1758232860000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000043673"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,1]]},"references-count":24,"journal-issue":{"issue":"31","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043673","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,1]]},"assertion":[{"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}